Foslevodopa
An overview of the prodrug Foslevodopa used in the treatment of Parkinson's disease
Foslevodopa is a prodrug of levodopa, which is primarily used in the management of Parkinson's disease. It is designed to improve the pharmacokinetic properties of levodopa, enhancing its absorption and bioavailability. This article provides a comprehensive overview of foslevodopa, including its mechanism of action, clinical applications, pharmacokinetics, and potential side effects.
Mechanism of Action[edit | edit source]
Foslevodopa is a phosphate ester of levodopa. Once administered, it is rapidly converted into levodopa in the body. Levodopa is a precursor to dopamine, a neurotransmitter that is deficient in the brains of patients with Parkinson's disease. By increasing dopamine levels, foslevodopa helps alleviate the motor symptoms associated with the disease, such as tremors, rigidity, and bradykinesia.
Clinical Applications[edit | edit source]
Foslevodopa is used in the treatment of Parkinson's disease, particularly in patients who experience fluctuations in response to standard levodopa therapy. It is often used in combination with other medications, such as carbidopa, to enhance its efficacy and reduce peripheral side effects.
Pharmacokinetics[edit | edit source]
Foslevodopa is designed to improve the pharmacokinetic profile of levodopa. It is more soluble in water, which allows for better absorption in the gastrointestinal tract. Once absorbed, it is rapidly converted to levodopa by the action of phosphatases. This conversion process helps maintain more stable plasma levels of levodopa, potentially reducing the "on-off" phenomena experienced by patients.
Side Effects[edit | edit source]
The side effects of foslevodopa are similar to those of levodopa. Common side effects include nausea, dizziness, and orthostatic hypotension. Long-term use may lead to dyskinesias, which are involuntary movements that can be distressing to patients. It is important to monitor patients for these side effects and adjust the dosage accordingly.
Also see[edit | edit source]
Template:Parkinson's disease treatments
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
